Dataset Information

Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic.

ABSTRACT:

Motivation

Identification of transcriptional regulatory networks (TRNs) is of significant importance in computational biology for cancer research, providing a critical building block to unravel disease pathways. However, existing methods for TRN identification suffer from the inclusion of excessive 'noise' in microarray data and false-positives in binding data, especially when applied to human tumor-derived cell line studies. More robust methods that can counteract the imperfection of data sources are therefore needed for reliable identification of TRNs in this context.

Results

In this article, we propose to establish a link between the quality of one target gene to represent its regulator and the uncertainty of its expression to represent other target genes. Specifically, an outlier sum statistic was used to measure the aggregated evidence for regulation events between target genes and their corresponding transcription factors. A Gibbs sampling method was then developed to estimate the marginal distribution of the outlier sum statistic, hence, to uncover underlying regulatory relationships. To evaluate the effectiveness of our proposed method, we compared its performance with that of an existing sampling-based method using both simulation data and yeast cell cycle data. The experimental results show that our method consistently outperforms the competing method in different settings of signal-to-noise ratio and network topology, indicating its robustness for biological applications. Finally, we applied our method to breast cancer cell line data and demonstrated its ability to extract biologically meaningful regulatory modules related to estrogen signaling and action in breast cancer.

Availability and implementation

The Gibbs sampler MATLAB package is freely available at http://www.cbil.ece.vt.edu/software.htm.

Contact

xuan@vt.edu

Supplementary information

Supplementary data are available at Bioinformatics online.

SUBMITTER: Gu J

PROVIDER: S-EPMC3400952 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundOne of the goals of the Systems Biology community is to have a detailed map of all biological interactions in an organism. One small yet important step in this direction is the creation of biological networks from post-genomic data. Bayesian networks are a very promising model for the inference of regulatory networks in Systems Biology. Usually, Bayesian networks are sampled with a Markov Chain Monte Carlo (MCMC) sampler in the structure space. Unfortunately, conventional MCMC sampling schemes are often slow in mixing and convergence. To improve MCMC convergence, an alternative method is proposed and tested with different sets of data. Moreover, the proposed method is compared with the traditional MCMC sampling scheme.ResultsIn the proposed method, a simpler and faster method for the inference of regulatory networks, Graphical Gaussian Models (GGMs), is integrated into the Bayesian network inference, trough a Hierarchical Bayesian model. In this manner, information about the structure obtained from the data with GGMs is taken into account in the MCMC scheme, thus improving mixing and convergence. The proposed method is tested with three types of data, two from simulated models and one from real data. The results are compared with the results of the traditional MCMC sampling scheme in terms of network recovery accuracy and convergence. The results show that when compared with a traditional MCMC scheme, the proposed method presents improved convergence leading to better network reconstruction with less MCMC iterations.ConclusionsThe proposed method is a viable alternative to improve mixing and convergence of traditional MCMC schemes. It allows the use of Bayesian networks with an MCMC sampler with less iterations. The proposed method has always converged earlier than the traditional MCMC scheme. We observe an improvement in accuracy of the recovered networks for the Gaussian simulated data, but this improvement is absent for both real data and data simulated from ODE.

Project description:BackgroundPilocytic Astrocytomas (PAs) are common low-grade central nervous system malignancies for which few recurrent and specific genetic alterations have been identified. In an effort to better understand the molecular biology underlying the pathogenesis of these pediatric brain tumors, we performed higher-order transcriptional network analysis of a large gene expression dataset to identify gene regulatory pathways that are specific to this tumor type, relative to other, more aggressive glial or histologically distinct brain tumours.MethodsRNA derived from frozen human PA tumours was subjected to microarray-based gene expression profiling, using Affymetrix U133Plus2 GeneChip microarrays. This data set was compared to similar data sets previously generated from non-malignant human brain tissue and other brain tumour types, after appropriate normalization.ResultsIn this study, we examined gene expression in 66 PA tumors compared to 15 non-malignant cortical brain tissues, and identified 792 genes that demonstrated consistent differential expression between independent sets of PA and non-malignant specimens. From this entire 792 gene set, we used the previously described PAP tool to assemble a core transcriptional regulatory network composed of 6 transcription factor genes (TFs) and 24 target genes, for a total of 55 interactions. A similar analysis of oligodendroglioma and glioblastoma multiforme (GBM) gene expression data sets identified distinct, but overlapping, networks. Most importantly, comparison of each of the brain tumor type-specific networks revealed a network unique to PA that included repressed expression of ONECUT2, a gene frequently methylated in other tumor types, and 13 other uniquely predicted TF-gene interactions.ConclusionsThese results suggest specific transcriptional pathways that may operate to create the unique molecular phenotype of PA and thus opportunities for corresponding targeted therapeutic intervention. Moreover, this study also demonstrates how integration of gene expression data with TF-gene and TF-TF interaction data is a powerful approach to generating testable hypotheses to better understand cell-type specific genetic programs relevant to cancer.